Investment Thesis
INVO Fertility is in severe financial distress with negative profitability across all margins, critical liquidity crisis (current ratio of 0.12x), and substantial cash burn exceeding $7M annually. The company is losing $481.80 for every dollar of revenue generated, indicating fundamental business model challenges that cannot be attributed to early-stage development.
Strengths
- Debt/Equity ratio of 0.34x indicates relatively moderate leverage
- Minimal capital expenditure suggests controlled cash outflow in non-operating areas
- Presence in surgical medical instruments sector provides potential market opportunity
Risks
- Critical liquidity crisis with current ratio of 0.12x and only $355.9K cash against $13.0M liabilities
- Catastrophic profitability: -481.8% net margin and -110.8% operating margin indicating unsustainable business model
- Severe cash burn with operating cash flow of -$7.0M and free cash flow of -$7.1M threatening near-term solvency
- Revenue of only $5.3M with negative growth (-0.4% YoY) and minimal gross margin of 5.2%
- Net loss of $25.3M substantially exceeds annual revenue by 477%, indicating massive operating losses
Key Metrics to Watch
- Cash position and burn rate trajectory to assess solvency timeline
- Operating cash flow and path to positive FCF generation
- Revenue growth and gross margin expansion to validate business model viability
- Liquidity ratios and ability to meet near-term obligations
Financial Metrics
Revenue
5.3M
Net Income
-25.3M
EPS (Diluted)
$-17.83
Free Cash Flow
-7.1M
Total Assets
18.8M
Cash
355.9K
Profitability Ratios
Gross Margin
5.2%
Operating Margin
-110.8%
Net Margin
-481.8%
ROE
-433.1%
ROA
-134.5%
FCF Margin
-134.5%
Balance Sheet & Liquidity
Current Ratio
0.12x
Quick Ratio
0.10x
Debt/Equity
0.34x
Debt/Assets
68.9%
Interest Coverage
N/A
Long-term Debt
2.0M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-29T15:44:10.272640 |
Data as of: 2025-09-30 |
Powered by Claude AI